Petrus Trust Company’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,727
Closed -$271K 76
2025
Q3
$271K Buy
4,727
+881
+23% +$50.7K 0.03% 51
2025
Q2
$227K Sell
3,846
-9,324
-71% -$602K 0.02% 427
2025
Q1
$964K Buy
13,170
+3,622
+38% +$299K 0.09% 41
2024
Q4
$790K Buy
9,548
+4,114
+76% +$324K 0.08% 76
2024
Q3
$389K Buy
+5,434
New +$384K 0.04% 323
2024
Q2
Sell
-10,929
Closed -$586K 652
2024
Q1
$586K Buy
+10,929
New +$588K 0.05% 143
2023
Q4
Sell
-8,186
Closed -$406K 656
2023
Q3
$406K Buy
8,186
+958
+13% +$53.6K 0.04% 258
2023
Q2
$430K Sell
7,228
-2,466
-25% -$141K 0.05% 213
2023
Q1
$549K Buy
+9,694
New +$622K 0.07% 63

Other funds holding GMED

Petrus Trust Company's GMED Position: Q4 2025 in Review

Petrus Trust Company sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 4,727 shares — an estimated $271K sold.

Petrus Trust Company first reported a position in GMED in Q1 2023 and held it in 9 quarters. The position peaked at $964K in Q1 2025. 563 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Petrus Trust Company reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • Petrus Trust Company sold 4,727 Globus Medical shares in Q4 2025, an estimated $271K.
  • Petrus Trust Company first reported a position in Globus Medical in Q1 2023 and held it in 9 quarters.
  • Petrus Trust Company's Globus Medical position peaked at $964K in Q1 2025.
  • 563 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Petrus Trust Company's 13F filing for Q4 2025, filed 17 Feb 2026.